7 results
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Causes of Breakthrough ... #Anticoagulation ... Thrombosis #Algorithm ... Extension #VTE #DVT ... #Hematology #Management
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
Recurrent / Breakthrough ... DVT During Anticoagulation ... #Recurrent #DVT ... #hematology #differential ... #algorithm
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Extremity Venous Thrombosis ... Superficial #Deep #VTE #DVT ... #Hematology #Management ... #Anatomy #Anticoagulation ... #Algorithm
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
Extremity Venous Thrombosis ... Superficial #Deep #VTE #DVT ... #Hematology #Management ... #Anatomy #Anticoagulation ... #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... DVT = deep vein ... #Anticoagulation ... #Management #Hematology ... #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... catheter-related thrombosis ... #Anticoagulation ... #Management #Hematology ... #Oncology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... • Treatment algorithms ... Hydroxyurea + anticoagulation ... Thrombocythemia #ET #hematology ... diagnosis #management #hematology